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Abstract
Imbalance of the excitatory neurotransmitter glutamate and of the inhibitory neurotransmitter GABA is one of several
causes of seizures. ATP has also been implicated in epilepsy. However, little is known about the mechanisms involved in the
release of ATP from cells and the consequences of the altered ATP signaling during seizures. Pannexin1 (Panx1) is found in
astrocytes and in neurons at high levels in the embryonic and young postnatal brain, declining in adulthood. Panx1 forms
large-conductance voltage sensitive plasma membrane channels permeable to ATP that are also activated by elevated
extracellular K
+ and following P2 receptor stimulation. Based on these properties, we hypothesized that Panx1 channels may
contribute to seizures by increasing the levels of extracellular ATP. Using pharmacological tools and two transgenic mice
deficient for Panx1 we show here that interference with Panx1 ameliorates the outcome and shortens the duration of kainic
acid-induced status epilepticus. These data thus indicate that the activation of Panx1 in juvenile mouse hippocampi
contributes to neuronal hyperactivity in seizures.
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Introduction
Among the various types of paracrine signals, purinergic ATP-
mediated signaling is emerging as one of the most prominent form
involved in neural cell interactions (reviewed in [1]). This is
because all neural cell types are able to release and respond to
ATP and/or its metabolites. Purinergic signaling is not only
involved in physiological glia-glia and glia-neuronal communica-
tion, but also plays critical roles in events related to epileptogen-
esis. Generalized seizures were reported after microinjection of
ATP into the pre-piriform cortex and augmented levels of ATP
were measured in hippocampi of mice with audiogenic seizures
([2]; but see [3]; reviewed in [4]).
Recently, Pannexin1 (Panx1) in pyramidal neurons was found to
contribute to NMDA-mediated epileptiform activity by increasing
spike amplitude and decreasing burst intervals [5]. Pannexins (Panx 1,
2, and 3) are a group of proteins that share sequence homologies with
the invertebrate gap junction proteins, the innexins. Differently,
however, from their homologues, pannexins do not form gap junction
intercellular channels, but do form plasma membrane channels, at least
in the case of Panx1. Panx1 transcripts have been shown to be
expressed in the CNS, at high levels in early stages of murine brain
development, decreasing in adulthood [6].
When exogenously expressed, Panx1 forms large conductance
(500pS) channels that are permeable to ATP [7]. These channels
have been reported to be activated by voltage, by mechanical
stretch, by elevated extracellular K
+, and following P2 receptor
activation [8,9,10]. Moreover, Panx1 is associated with the P2X7
receptor [11,12], and, at least in astrocytes, this association is
essential for the ATP-induced ATP release mechanism involved in
the transmission of calcium signals among these cells [13,14,15].
Intense neuronal activity, such as that occurring during
epileptiform convulsions can elevate extracellular K
+ to levels that
promote opening of Panx1 channels. Here we tested the
hypothesis that Panx1 channels contribute to seizures by releasing
the excitatory nucleotide ATP, using a Panx1 channel blocker and
two different Panx1-null mice (Panx1
2/2 and Panx1 KOfirst).
Our results indicate that Panx1 channels are opened by elevated
K
+ concentration and following kainic acid-induced status
epilepticus and that blockade or deletion of Panx1 reduces the
amount of ATP that is released and improves the behavioral
manifestation of seizures.
Materials and Methods
Ethics Statement
Mice were housed and maintained under specific pathogen-free
conditions in the Animal Resource Facilities of the University of
Geneva and the Albert Einstein College of Medicine and all
experiments were pre-approved by the Animal Care and Use
Committee (IACUC approval numbers AUP # 2010-0414 and
1034/3552/1).
Animals
Wild-type and Panx1-null mice (postnatal day 13–14), all on the
C57Bl/6 background, were used (Fig. S1). All procedures were
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the local veterinary authorities. We used two different Panx1
transgenic mice, the Panx1
2/2 mice generated by Dr. Hannah
Monyer [16] and the heterozygote Panx1-knockout (KO)first
(Panx1
tm1a(KOMP)Wtsi) mice generated and purchased from KOMP
at UCDavis, an NIH initiative. Panx
+/2 mice were maintained at
the animal facility at the University of Geneva. Panx1 KOfirst
heterozygotes were bred to homozygosity and maintained in the
animal facility at Albert Einstein College of Medicine.
Genotyping
Panx1
2/2 mice were genotyped by PCR of tail DNA (0.5 ml)
using 3 primers (a:5 9GGAAAGTCAACAGAGGTACCC39; b:
59CTTGGCCACGGAGTATGTGTT39; c:5 9GTCCCTCTCA-
CCACTTTTCTTACC39). The wild type Panx1 allele was
targeted by primers a and b, and was identified by a 330 bp
amplicon, whereas the mutated allele was targeted by primers a
and c, and was identified by a 630 bp amplicon (Fig. S1). Real-
time quantitative polymerase chain reaction was used to amplify
RNA extracted from the hippocampi of 3 mice per genotype using
RNeasyH Micro Kit (Qiagen AG, Basel, Switzerland). RNA
samples were then treated with DNase I. One mg total RNA was
reverse transcribed using random hexamers Superscript III reverse
transcriptase (Invitrogen, Grand Island, NY, USA), and amplified
using single stranded oligonucteotides for Panx1 (sense: TA-
TTGCCGTGGGTCTACCTC; antisense: TGTCGCCAGGA-
GAAAGAACT) designed for SYBR green assays using the
program Primer Express v 2.0 (Applied Biosystems, Foster City,
CA, USA) and a SDS 7900 HT instrument (Applied Biosystems).
Each reaction was performed in three replicates on 384-well
plates. Raw Ct values obtained with SDS 2.2 (Applied Biosystems)
were normalized to the geometric mean of 3 stable genes (eef1a1,
gapdh, gusb), and used to calculate fold-changes by the GeNorm
method.
Panx1 KOfirst were genotyped by tail PCR using 4 primers (1:
59GAGATGGCGCAACGCAATTAAT39; 2:5 9CTGGCTCT-
CATAATTCTTGCCCTG39; 3:5 9 CTGTATCACACAACCA-
CTTCAGAGAAGG39; 4:5 9GAGCTGACCCCTTTCCATT-
CAATAG39). The wild type Panx1 allele was targeted by primers
3 and 4 and identified as a 579 bp amplicon, while the transgene
was targeted by primers 1 and 2 and identified as a 381 bp
amplicon (Fig. S1). Western blots were used to evaluate Panx1
protein deletion in cultured brain astrocytes of Panx1 KOfirst
(Fig. S1).
Immunohistochemistry
Coronal cryosection of p-formaldehyde fixed hippocampi were
immunostained using anti-Panx1 (Aves Lab), anti-GFAP (Sigma),
and anti-NeuN (Milipore) antibodies. Isotype specific, Alexa Fluo
secondary antibodies were used to identify the cellular distribution
of these proteins using a Zeiss LSM 510 Duo confocal microcope
equipped with a 636oil immersion objective and META spectral
detection system.
Western blot
Cell lysates of cultured astrocytes derived from WT and Panx1
KOfirst neonate mouse brains were electrophoresed in 4–20%
mini-gels. After transfer of proteins to nitrocellulose membranes
and one hour incubation in blocking phosphate buffered solution
(PBS) containing 0.5% Tween-20 and 2% skinned milk, blotting
was performed for two hours at room temperature (RT) using anti-
Panx1 antibodies (1:1000; Aves Lab) and for 1 hr when using anti-
GAPDH (Fitzgerald). After washes with PBS-Tween-20, mem-
branes were incubated with goat anti-chicken or goat anti-mouse
HRP-conjugated secondary antibodies (1:2000; Santa Cruz
Technology) for one hour at RT. Visualization of bands was
performed using X-ray film and a developer.
Brain slices
Coronal sections (350 mm thick) of P13–P14 mouse brains were
obtained using a tissue chopper (Ted Pella Inc.). After cutting,
brain slices were immediately placed in Hepes buffered, air-
bubbled ACSF (145 mM NaCl, 2.5 mM KCl, 3.1 mM CaCl2,
1.3 mM MgCl2, 10 mM glucose, 10 mM Hepes, pH 7.4), and
maintained at 30uC. After 30–40 min, ACSF was exchanged for
the appropriate ACSF necessary for each experimental condition
(see below).
Dye uptake
Panx1 activation was evaluated in acute hippocampal slices
using a modified method of dye uptake, previously described
[11,13,15]. Briefly, brain slices were incubated for 1 hr, at 30uC,
in Hepes-buffered air-bubbled ACSF containing the dye (5 mM),
in the absence and presence of mefloquine (MFQ: 100 nM;
BioBlocks QU-024). After that, YoPro solution was removed and
slices washed 3 times, 10 min each with 5 ml ACSF. After the last
wash, brain slices were fixed overnight, at 4uC, in 4% p-
formaldehyde, and then transferred to ice-cold ACSF containing
30% sucrose for few hours and hippocampal slices isolated from
the surrounding brain tissue. YoPro1 uptake in hippocampi
following exposure to ACSF containing 2.5 mM and 10 mM K
+
concentrations (osmolarity adjusted with equimolar concentration
of NaCl) and after kainic acid induced status epilepticus was
measured from regions of interest placed on the pyramidal cell
layer (CA1–CA3) and stratum radiatum of p-formaldehyde fixed
tissues using an Nikon inverted microcope equipped with 46
objective, 488/512 nm filter sets and Metafluor software.
ATP release
The amount of ATP released into the ACSF by acute brain
slices was measured as previously described [15,17,18], using the
luciferin/luciferase assay (Molecular Probes and Promega) and a
Turner luminometer. Fifty ml of the 5 ml ACSF bathing the brain
slices were collected every 15 min during one hour and stored at
220uC until use. After that time, brain slices were sonicated in
lysis buffer (150 mM NaCl; 10 mM Tris-base; 1% TritonX-100;
protease inhibitor cocktail; pH 7.4) and total protein measured
using the BCA reagents (Thermo Scientifc). The concentrations of
ATP released from brain slices were obtained from standard
curves and normalized to the total amount of protein.
Kainic acid-induced seizures
Mice were injected intraperitoneally (i.p.) with kainic acid (3.2–
3.6 mg/kg body weight; Sigma) and maintained in a temperature
controlled environment for observation of seizures. Seizure
monitoring was done for up to 2 hours after the onset of status
epilepticus (SE). In some experiments, mice were injected i.p. with
the Panx1 channel blocker MFQ (0.4 mg/kg body weight) 2 hr
prior to kainic acid injection. After experimentation, mice were
euthanized by decapitation and coronal brain sections collected for
further functional testing.
To determine the effective kainic acid concentration necessary
to induce sustained status epilepticus for at least two hours in
juvenile (P13–P14) mice, we injected a range (3.0–4.0 mg/kg) of
kainic acid concentration. The dose that produced 2 hrs of
sustainable SE and the lowest mortality was then chosen. We used
3.6 mg/kg body weight to inject WT and Panx1 KOfirst mice.
Pannexin1 and Seizures
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observers when evaluating KA-induced SE in WT and Panx1
KOfirst mice and the effects of Panx1 blocker MFQ on KA-
induced SE in WT mice. Control experiments were always
performed in parallel (saline-injected vs KA-injected WT mice,
and MFQ- and KA-injected vs KA-injected mice). Blind
experiments were performed when using Panx1
2/2 transgenic
mice. In this case, litters derived from Panx1
+/+6Panx1
+/2 and
from Panx1
+/26Panx1
2/2 breeding were tested prior to animal
genotyping. Due to the remodeling of the animal facility at the
University of Geneva that occurred during the experimentation
period and influenced mouse breeding and behavior, the dose of
3.6 mg/kg kainic acid used initially had to be re-adjusted to
3.2 mg/kg to avoid a high incidence of animal mortality. Data
obtained from the initial studies using 3.6 mg/kg KA-injected
Panx1
+/+ and Panx1
2/2 mice did not differ statistically from those
obtained from 3.2 mg/kg KA-injected Panx1
+/+ and Panx1
2/2
mice and therefore were grouped for analyses. We used at Albert
Einstein a total of 33 WT and 6 Panx1 KOfirst mice. Of the 51
P13-P14 Panx1 transgenic mice tested in Geneva, 12 were
Panx1
+/+, 26 were Panx1
+/2 and 13 were Panx1
2/2. Data
obtained from animals that died (2 Panx1
+/+, 3 Panx1
+/2,3
Panx1
2/2) during the course of 3.6 mg/kg KA-induced SE were
discarded from analyses.
Results
Hipocampal neurons and astrocytes express pannexin1
Although Panx1 transcripts have been detected in the rodent
CNS [6,19,20], there is only one report indicating Panx1 protein
expression in hippocampal and cortical neurons in situ [21]. Yet,
Panx1 expression in astrocytes has only been observed in cell
culture preparations [15,22]. Our immunohistochemistry per-
formed on P14 mouse hippocampi confirmed the presence of
Panx1 in both neurons and astrocytes, as identified by NeuN and
GFAP positive cells, respectively, and its absence in Panx1
2/2
mice (Fig. 1). Note in WT animals the intense Panx1 staining on
cell bodies of neurons in the pyramidal cell layer of the CA1 region
of the hippocampus and on stratum radiatum astrocyte cell bodies
as well as along the astrocyte endfeet surrounding blood vessels.
Figure 1. Pannexin1 is expressed in astrocytes and neurons in the hippocampus. Confocal images of the stratum radiatum (A1–A4) and
pyramidal cell layer (B1–B4) of the CA1 hippocampal region of P14 WT mice showing that GFAP-positive astrocytes and NeuN-positive hippocampal
neurons express Panx1; nuclei were counterstained with DAPI. Note in (C1–C4) the lack of staining in the pyramidal cell layer from Panx1
2/2 mice.
Merged images are shown in A4, B4 and C4. Arrows and arrow heads in A3–4 indicate Panx1 staining in astrocyte cell bodies and endfeet,
respectively. Bar: 15 mm.
doi:10.1371/journal.pone.0025178.g001
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2/2 mice (tail PCR and
qRT-PCR) as well as the Panx1 KOfirst (tail PCR and western
blot) are displayed in Figure S1.
High extracellular potassium opens Panx1 channels in
hippocampal slices
We evaluated whether Panx1 channels were activated under
conditionsofneuronal hyperactivitybymeasuringthecellularinflux
of YoPro1 in hippocampal slices exposed for 1 hr to artificial
cerebrospinal fluid (ACSF) containing 10 mM K
+. Under these
conditions, a significantly higher YoPro1 uptake in both the
hippocampal pyramidal cell layer and stratum radiatum was
recorded compared to that measured in normal (2.5 mM K
+)
ACSF (Fig. 2). Under elevated extracellular K
+, the amount of dye
uptake measured in pyramidal neurons was substantially higher
than in stratum radiatum astrocytes (Figs. 2A–B). Evidence that
YoPro1 stained cells in the stratum radiatum are astrocytes was
obtained by staining the slices with Texas Red hydrazide, a fixable
form of the astrocyte marker, sulforhodamine101 [23]. As shown in
Figure 3, the great majority of YoPro1 positive cells in the stratum
radiatumwere alsoTxRpositivecells;veryfewYoPro1positivecells
did not display the astrocyte marker which were likely interneurons.
Evidence that Panx1 mediated the YoPro1 dye influx was
obtained by blocking Panx1 with mefloquine (MFQ) which we
previously found to block these channels [24] and by using Panx1-
KOfirstmice.AsshowninFig.2A,incubationofhippocampalslices
for 1 hr in ACSF (10 mM K
+) containing YoPro1 and 100 nM
MFQ greatly reduced the influx of the dye. Similar observations
were made after intraperitoneal injection of MFQ (0.4 mg/kg) in
P14 mice, 2 hr before brains were removed and hippocampal slices
incubated for 1 hr with ACSF containing 10 mM K
+ (Fig. 2B). As
expected, compared to WT significantly lower dye uptake was
recordedfromhippocampalslicesofPanx1KOfirstmiceexposedto
elevated K
+ ACSF (Fig. 2A). Under this condition, we also found
augmented levels of ATP in the 5 ml of ACSF bathing the slices of
WT mice which increased 1. 9 fold from a basal level of 0.1660.01
to 0.3160.01 nM ATP/mg protein when the slices were exposed to
high K
+ ACSF (Fig. 2C). Blockade or deletion of Panx1 channels
attenuated the amount of ATP release induced by 10 mM K
+.I n
both of these cases, high K
+ ACSF caused a 1.4 fold increase in the
amount of ATP released (MFQ: 0.2260.01 nM ATP/mg protein,
N=6 animals; Panx1 KOfirst: 0.2260.01 nM ATP/mg protein,
N=6 animals) (Fig. 2C). No significant difference was obtained
when the amount of ATP released from MFQ-treated WT and
Panx1 KOfirst slices were compared. These results support the
hypothesis that elevated extracellular K
+ as occurs during
epileptiform discharges [25] activates Panx1 channels leading to
increased YoPro1 uptake and ATP release.
Pannexin1 channels are activated during status epileticus
Evidence that Panx1 is activated during epileptiform activity
was obtained by measuring the influx of YoPro1 in hippocampal
slices from juvenile P13–14 mice in which status epilepticus (SE)
was induced by i.p. injection of kainic acid (KA: 3.6 mg/kg).
Compared to saline-injected mice, a significant increase in YoPro1
uptake was measured in the pyramidal cell layer and in stratum
radiatum 2 hrs after KA-induced SE (Fig. 4). This effect was
largely reduced by i.p. injection of MFQ (0.4 mg/kg), 2 hrs prior to
KA injection (Fig. 4A gray bars). To further test whether this
increase in dye uptake was mediated by Panx1 channels, we
injected KA in Panx1
2/2 and in Panx1 KOfirst mice. We found
that hippocampal slices from these animals did not feature the
uptake of YoPro1 observed in KA-injected wild-type (WT) mice
(Fig. 4A, compare black, with either red or green bars).
Two hours after the onset of SE, extracellular ATP levels
recorded from ACSF bathing the slices of KA-injected WT mice
were significantly increased 2.09 fold over the values recorded from
saline-injected mice (Fig. 4B). Under this condition, extracellular
ATP levels increased from a basal level of 0.1860.02 nM/mg
protein recorded from slices of saline injected mice to a level of
0.3660.02 nM/mg protein when measured from slices of KA-
injected mice. After in vitro incubation of slices from KA-injected
mice with 100 nM MFQ, the amount of ATP was reduced to
0.2960.02 nM/mg protein, a level corresponding to 1.7 fold the
basal level (Fig. 4B). The amount of ATP measured from slices of
KA-injected Panx1 KOfirst mice (0.2060.02 nM/mg protein) was
1.3 fold basal levels (Fig. 4B), which was not significantly different to
that of KA-injected Panx1
2/2 (0.2160.03 nM/mg protein). These
data show that Panx1 channels are activated during in vivo neuronal
hyperactivity,likelycontributingtothe non-vesicularreleaseofATP
which increases the extracellular levels of this excitatory transmitter.
Pannexin1 contributes to status epilepticus: A behavioral
analysis
To determine the role of Panx1 in the behavioral manifestations
of SE, we evaluated whether blockade of Panx1 channel with MFQ
Figure 2. Blockade or deletion of Panx1 channels prevents membrane permeabilization of hippocampal neurons and astrocytes
and attenuates ATP release from brain slices. Bar histograms showing the fractional mean 6 s.e.m. values (test/control: normalized to 2.5 mM
K
+ ACSF) of YoPro1 uptake induced by 10 mM K
+ in the pyramidal cell layer and stratum radiatum obtained in the absence and following (A) slice
incubation and (B) animal injection with MFQ. A substantial reduction in dye uptake was recorded from slices of Panx1 KOfirst mice exposed to high
K
+ ACSF (red bars). (C) Bar histograms showing the fractional mean 6 s.e.m. amounts of ATP present in the bathing solution of hippocampal slices
exposed for 1 hr to ACSF containing either 2.5 or 10 mM K
+. Note the increased release of ATP in 10 mM K
+ and its reduction following the blockade
(MFQ: 100 nM) and deletion (Panx1 KOfirst mice) of Panx1 channels. Data displayed in panels A and B are from 3 wild type and 4 Panx1 KOfirst mice
per group. The number of animals used in part C is in parentheses. ***P,0.001 and *P,0.05 between control and test conditions; ###P,0.001,
##P,0.01, and #P,0.05 between test conditions. P values were obtained from One-way Anova analysis of variance followed by Bonferroni’s
multiple comparison tests.
doi:10.1371/journal.pone.0025178.g002
Pannexin1 and Seizures
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outcomeofseizures.Forthat,we used thesame paradigmemployed
to measure dye influx in hipocampal slices, namely i.p. injection of
KA,toevaluatethebehavioralmanifestationsofseizuresinducedby
KA. The SE scoring system used was: 0 (normal), 1 (frozen and
leaning), 2 (scratching), 3 (forelimb stiff), 4 (unilateral forelimb
clonus), 5 (bilateral forelimb clonus), 6 (fore- and hind-limb clonus),
and 7 (tonic clonic seizures).
Besides registering the time course of seizure evolution, we
also used the following parameters to evaluate the behavioral
Figure 3. Dye uptake in hippocampal astrocytes. (A–C) Epifluorescence images of 4% p-formaldehyde fixed hippocampal slices derived from
WT mice that were exposed for 1 hr to (A) 2.5 mM and to (B–C) 10 mM K
+ ACSF containing 5 mM YoPro1 in the absence (B) and presence (C) of
100 nM MFQ. YoPro1 fluorescence intensity was measured from regions of interest placed along the neuronal cell bodies in the pyramidal cell layer
(Py; red circles) and in the stratum radiatum (SR; yellow circles) of the hippocampal CA1–CA3 regions. Images were acquired using an inverted
epifluorescence Eclipse Nikon microscope equipped with 46objective controlled by Metafluor software. (D) Confocal images of cells located in the
stratum radiatum of the mouse hippocampus that was exposed to 10 mM K
+ ACSF containing YoPro1 and the fixable astrocyte marker
sulforhodamine 101 (Texas Red hydrazide), showing that the great majority of YoPro1-positive cells were also stained with Texas Red. Arrows indicate
a few YoPro1-positive cells in the stratum radiatum that did not incorporate Texas Red (likely interneurons). Bar: 150 mm for top panels and 25 mm for
bottom panels.
doi:10.1371/journal.pone.0025178.g003
Figure 4. Panx1 channels contribute to membrane permeabilization during status epilepticus in mice. (A) Bar histograms showing the
fractional mean 6 s.e.m. values of YoPro1 uptake in pyramidal cell layer and stratum radiatum of hippocampi of WT mice that were injected with
saline (white bars), KA (black bars), MFQ and KA (gray bars), from hippocampi of KA-injected Panx1
2/2 (green bars) and Panx1 KOfirst (red bars) mice.
(B) Bar histograms of the fractional mean 6 s.e.m. values of ATP present in ACSF solutions bathing brain slices of saline-injected (white bar) and KA-
injected (black and hashed bars) WT mice in the absence (black bar) and presence (gray bar) of 100 nM MFQ, and from brain slices of Panx1
2/2
(green bars) and Panx1 KOfirst mice (red bars). Numbers in parentheses in parts A and B are the numbers of animals used. ***P,0.001 between
control and test conditions; ###P,0.001 and ##P,0.01 between test conditions. Significance calculated using One-way Anova analysis of
variance followed by Bonferroni’s multiple comparison tests.
doi:10.1371/journal.pone.0025178.g004
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25178manifestations of KA-induced seizures: (a) overall seizure scores
recorded during the observation period, as measured by the area
under the curve (seizure score6time), (b) the time necessary to
display middle range seizure score, as being the time to the onset
of stage 3 (forelimb stiff), (c) the worst seizure score recorded any
time during the observation period, and (d) the end point of seizure
scoring.
As shown in Figure 5A, soon after KA injection, WT mice
started displaying behavioral manifestations of seizures that
progressed from stage 1 (frozen and leaning) to stage 6 (fore-
and hind-limb clonus) within 60 min after injection. During the
remaining period of analysis, seizure scores stabilized around levels
5 and 6.
Compared to KA-injected WT mice, a significant improvement
in behavioral outcome was obtained when Panx1 channels were
blocked or deleted (Figs. 5A–F). The overall seizure score,
measured as the mean6s.e.m. values of the areas under the
curves (seizure score6time), was significantly decreased from
619.2632.9 to 446.0651.9 score6sec when Panx1 was blocked by
i.p. injection of MFQ prior to KA injection (Figs. 5A, C). A
significant decrease in the overall seizure scores, compared to that
of WT mice, was also obtained for the two Panx1-null (Panx1
2/2
and Panx1-KOfirst) mice; the mean6s.e.m. values of the areas
under the curves for these transgenic mice were 328.3662.0 and
319.3672.5 score6sec (Fig. 5C). No significant difference in terms
of overall scores was observed between the two Panx1-null
(Panx1
2/2 and Panx1-KOfirst) mice and between these trans-
genics and the MFQ-treated WT mice (Fig. 5C). The deletion or
blockade of Panx1 channels did not alter the onset time to
forelimb stiff (score 3; Fig. 5D) and marginally improved the worst
seizure score (Fig. 5E). However, 60–70 min after KA injection, a
substantial and progressive improvement of seizure scores were
recorded, such that 2 hr after SE onset, seizure score significantly
decreased from a median value of 6 (interquartile range: 4–6) to
median values of 3 (interquartile range: 0–4) when Panx1 channels
were blocked with MFQ, and to a median values 0.5 when Panx1
was deleted (interquartile ranges: 0–4 for Panx1
2/2 and 0–1 for
Panx1 KOfirst) (Fig. 5F). No significant differences were obtained
Figure 5. Targeting Panx1 channels ameliorates seizure outcome. (A, B) Time courses of the mean 6 s.e.m. values of seizure scores
measured after intraperitoneal injection of KA in (A) WT mice untreated (black symbols) and MFQ-treated (gray symbols) mice, in (B) WT (black
symbols) and in two Panx1-null (Panx1
2/2: green symbols, Panx1 KOfirst: red symbols) mice. (C) Bar histograms of the mean 6 s.e.m. values obtained
for the overall seizure scores (score6time: area under the curves) displayed on the left panels. Note in panel C that MFQ-treated WT mice and the two
Panx1-null mouse lines displayed significant behavioral improvements (smaller areas under the curve) compared to WT mice and that the overall
seizure severity of MFQ-treated WT mice were not significantly different from those of two Panx1-null mouse lines. (D–E) Bar histograms of the (D)
mean 6 s.e.m. values of the onset time of forelimb stiff, and of the median 6 interquartile range values of (E) the worst seizure score recorded during
the time course of observation. Numbers in parentheses are the number of animals used in each group. Part F shows the scatter dot plots with their
respective median values of the seizure score at 2 hr after SE of KA-injected (black), MFQ- and KA -injected WT mice (gray), and KA-injected Panx1-null
(Panx1
2/2: green, Panx1 KOfirst: red) mice. Values in parts C and D are mean 6 s.e.m. and the indicated P values were obtained from One-way Anova
analysis of variance followed by Newman-Keuls multiple comparison test. Values in part E are medians with interquartile range, and horizontal lines in
part F are the median values obtained for the scatter dot plots. Indicated P values in parts E and F were obtained from non-parametric statistical
analysis Kruskal-Wallis of variance followed by Dunn’s test. In part D, only 9 animals were analyzed because one of ten Panx1
2/2 mice did not display
forelimb stiff.
doi:10.1371/journal.pone.0025178.g005
Pannexin1 and Seizures
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final seizure scores. These behavioral data indicate that Panx1
channels do not participate in the onset of KA-induced seizures,
but substantially contribute to sustain and prolong seizure activity.
Discussion
Using a variety of approaches and two transgenic mouse lines
where Panx1 is deleted, we provide evidence that channels formed
by this protein contribute to status epileticus in vivo. The data are
consistent with a model in which the intense neuronal activity that
occurs during epileptiform activity elevates extracellular K
+. The
increased extracellular concentration of this cation activates Panx1
channels, leading to the release of the excitatory transmitter ATP.
The activation of purinergic P2 receptors resulting from the
elevated extracellular ATP may further contributes to the
neuronal hyperactivity, thereby initiating a positive feedback
mechanism that accelerates the progression of seizures, worsens
their degree and extends their duration.
Our results show that Panx1 channels are activated in
hippocampal slices, as measured by the influx of the dye YoPro1,
under conditions of neuronal hyperactivity. These findings are
consistent with a previous report indicating opening of Panx1
channels in hippocampal neurons exposed to 100 mM NMDA
potentiates seizure-like activity [5]. In that report, blockade of
Panx1 channels with carbenoxolone or with the
10Panx1 peptide,
as well as the knockdown of Panx1 expression with shRNA, was
shown to prevent the NMDA receptor secondary current and dye
uptake that occurred several minutes after the initiation of
epileptiform discharges. The present study significantly extends
these in vitro observations by showing that two independent lines of
transgenic mice null for Panx1 did not display kainic acid-induced
Panx1 channel activity. These novel in vivo data, together with the
improvement of behavioral manifestations of seizure in the two
Panx1-null mouse lines and in wild-type mice treated with MFQ,
concur to indicate that Panx1 channels potentiate seizure activity.
The first evidence that Panx1 channels can be activated by
elevated extracellular K
+ concentrations was provided by Silver-
man et al. [10] using oocytes expressing Panx1 and a human
astrocytoma cell line. Under voltage clamp conditions, currents
sensitive to the Panx1 channel blocker carbenoxolone were shown
to be significantly larger when oocytes were bathed in solution
with elevated K
+ [10]. In this same study, the high K
+-induced
influx of YoPro1 in 1321N1 astrocytoma was also shown to be
totally prevented in cells in which Panx1 was knocked-down by
shRNA.
Results obtained in the present study provide evidence that in
situ and in vivo Panx1 channels can be opened by elevated K
+
concentrations at levels similar to those reported to occur under
intense neuronal activity [25]. Activation of Panx1 channels in
hippocampal neurons and astrocytes that leads to dye uptake and
ATP release from slices exposed to 10 mM K
+ and from slices of
KA-injected mice is here shown to be blocked by a potent agent
and in two transgenic mouse lines lacking Panx1.
Although not fully established, ATP through its action on P2X
receptors has long been proposed to be pro-convulsant
[2,26,27,28]. Increased levels of extracellular ATP have been
recorded from hippocampal slices of rats susceptible to
audiogenic seizures [2]. In this study, the authors detected,
using the luciferin/luciferase assay, 0.79–1.52 pmol of extracel-
lular ATP after stimulation of Schaffer collaterals of seizure-
susceptible D2 mice, which was about 2 fold higher than that
recorded from non-susceptible B6 mice. In agreement with this
study, we also found comparable elevated ATP levels (0.31–
0.36 nM: 1.55–1.80 pmol) in ACSF bathing brain slices exposed
to high K
+ and from those of KA-injected WT mice. Given that
the amount of ATP present in the ACSF bathing the slices of
Panx1-null mice was reduced to about 1.0 pmol, it is most likely
that a substantial amount (30–40%) of released ATP occurs via
Panx1 channels. Moreover, that Panx1-mediated ATP release is
an important event that contributes to prolong hyperexcitabilty
is provided from our results showing that suppression of Panx1
channels ameliorates the behavioral manifestations of status
epilepticus.
In contrast to the excitatory action of ATP, adenosine has a well
established anti-convulsant action by acting on adenosine A1
receptors. Activation of A1 receptor suppresses glutamate release
from pre-synaptic terminals [29] and hyperpolarizes post synaptic
neurons via ATP-sensitive potassium channels [30]. During
seizures, extracellular adenosine levels rise substantially [31], due
to the hydrolysis of ATP by ectonucleotidases [32], and to the
release of adenosine through the equilibrative nucleoside trans-
porters (ENTs) as a consequence of down-regulation/inhibiton of
adenosine kinase [33,34]. However, under conditions mimicking
status epilepticus, it was shown that the loss of adenosine-mediated
inhibition was correlated with the depletion of cellular ATP that
occurred during the spontaneous switch between seizure-like
events to late recurrent discharges [35]. It was also reported that
such a cellular depletion of ATP results in the reduction of the
phosphorylation state and function of the GABA-A receptors
leading to increased number of after-discharges [36]. Thus, based
on these reports, we can speculate that the beneficial effect seen
here in the Panx1-null mice could be resultant from the prevention
of total loss of cellular ATP that impairs animal recovery from
prolonged seizures. Alternatively or in addition, it is also possible
that the reduced release of ATP from Panx1-null mice could also
limit the activation of excitatory P2X receptors and thus the
progression of status epilepticus.
In summary, our results provide the first direct evidence that
Panx1 channels worsen seizures and sustain status epilepticus in
vivo. While further studies are now required to differentiate the
respective contributions of the neuronal and glial Panx1 and to
conclusively determine the contribution of ATP/P2X receptors to
this deleterious condition, the data open new perspectives for the
development of innovative therapeutic approaches which, by
targeting the Panx1, may be beneficial for the prevention and/or
treatment of status epilepticus.
Supporting Information
Figure S1 Characterization of two different Panx1-null
mice (Panx1
2/2 and Panx1 KOfirst). (A) PCR of mouse tail
DNA using primers specific for either the wild type or the mutated
allele, distinguished wild type (+/+), heterozygous (+/2) and
homozygous null Panx-1 mice (2/2). (B) Quantitative RT-PCR
showing the expression levels of Panx1 in the hippocampus of
Panx1
+/+ (black bar), Panx1
+/2 (grey bar) and Panx1
2/2 mice
(open bar). Values are mean 6 s.e.m. levels of the number of mice
indicated. *** p,0.001 Panx1
+/2 vs Panx1
+/+ mice, Panx1
2/2 vs
Panx1
+/2, and Panx1
2/2 vs Panx1
+/+ mice. Three animals of
each genotype were used. (C) Tail PCR products obtained using
specific primers designed to detect the wild type (WT) 579 bp, the
homozygous Panx1 KO-first (KO) 381 bp amplicons and the
heterozygous (HT) 579 and 381 bp amplicons. (D) Western blot
performed on cell lysates of cultured astrocytes obtained from two
WT and three Panx1 KOfirst neonate mice using anti-Panx1
antibodies. Membrane was re-probed with anti-GAPDH.
(TIF)
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